Diabetes Epidemiology Research International.Preventing insulin dependent diabetes mellitus: The environmental challenge. BMJ1987;295:479–81.
2.
BrewertonDACaffreyMHartFDJamesDCONichollsASturrockRD. Ankylosing spondylitis and HL-A 27. Lancet1973;i:904–7.
3.
BrewertonDACaffreyMFPJamesDCO. The histocompatibility antigen (HL-A 27) and its relation to disease. J Rheumatol1974;1:249–53.
4.
SinhaAABrautbarCSzaferF. A newly characterised HLA DQβ allele associated with pemphigus vulgaris. Science1988;239:1026–9.
5.
SheehyMJScharfSJRoweJR. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest1989;83:830–5.
6.
JulierCHyerRNDaviesJ. Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature1991;354:155–9.
7.
SvejgaardAPlatzPRyderLP. HLA and disease 1982 — A survey. Immunol Rev1983;70:193–218.
8.
GermainRN. Antigen presentation. The second class story. Nature1991;353:605–7.
9.
KisielowPTehHSBlüthmannHVon BoehmerH. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature1988;335:730–3.
10.
KapplerJWStaerzUWhiteJMarrackPC. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature1988;332:35–40.
11.
ReesAJPetersDKCompstonDASBatchelorJR. Strong association between HLA DRw2 and antibody mediated Goodpasture's syndrome. Lancet1978;i:966–8.
12.
McDevittHOPerryRSteinmanLA. Monoclonal anti-Ia antibody therapy in animal models of autoimmune disease. In: EveredDWheianJ, eds. Autoimmunity and autoimmune disease (Ciba Foundation Symposium 129). Chichester, UK: John Wiley & Sons, 1987:184.
13.
SakaiKMitchellDJHodgkinsonSJZamvilSSRothbardJBSteinmanL. Prevention of experimental allergic encephalomyelitis with peptides blocking T cell-MHC interaction. Proc Natl Acad Sci USA1989;86:9470–4.
14.
VandenbarkAAHashimGOffnerH. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature1989;341:541–4.
15.
Acha-OrbeaHMitchellDJTimmermanL. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell1988;54:263–73.
16.
BaischJMWeeksTGilesRHooverMStastnyPCapraDJ. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med1990;322:1836–41.
17.
BillJAppelVBPalmerE. An analysis of T-cell receptor variable region gene expression in major histocompatibility complex disparate mice. Proc Natl Acad Sci USA1988;85:9184–8.
HirayamaKMatsushitaSKikuchiIIuchiMOhtaNSasazukiT. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature1987;327:426–30.
20.
FielderAHLWalportMJBatchelorJR. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus; importance of null alleles of C4A and C4B in determining disease susceptibility. BMJ1983;286:425–8.
21.
HowardPFHochbergMCBiasWBArnettFCMcLeanRH. Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and Black Americans. Am J Med1986;81:187–93.
22.
WoodrowJC. Immunogenetics of systemic lupus erythematosus. J Rheumatol1988;15:197–9.
23.
GreenJRMontasserMWoodrowJC. The association of HLA-linked genes with systemic lupus erythematosus. Ann Hum Genet1986;50:93–6.
24.
HawkinsBRWongKLWongRWSChanKHDunckleyHSerjeantsonSW. Strong association between the major histocompatibility complex and systemic lupus erythematosus in Southern Chinese. J Rheumatol1987;14:1128–31.
25.
GoldsteinROlsenMLArnettFCDuvicMPollackMSReveilleJD. Deletion of C4A genes in Black Americans with systemic lupus erythematosus. Arthritis Rheum1988;31:S22. (Abstract).
26.
GlassDRaumDGibsonDStillmanJSSchurPH. Inherited deficiency of the second component of complement. Rheumatic disease associations, J Clin Invest1976;58:853–61.
27.
AgnelloV. Complement deficiency states. Medicine1978;57:1–23.
28.
RynesRI. Inherited complement deficiency states and SLE. Clin Rheum Dis1982;8:29–47.
29.
LachmannPJ. Complement — Friend or foe?. Br J Rheumatol1987;26:409–15.
30.
JacobCOFronekZLewisGDKooMHansenJAMcDevittHO. Heritable major histocompatibility complex class II-associated differences in production of tumour necrosis factor alpha: Relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA1990;87:1233–7.
31.
FronekZTimmermanLAAlperCA. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. Arthritis Rheum1990;33:1542–53.
32.
JacobCOMcDevittHO. Tumour necrosis factor-alpha in murine autoimmune ‘lupus' nephritis. Nature1988;331:356–8.
33.
FaustmanDLiXLinHY. Linkage of faulty major histocompatibility class I to autoimmune diabetes. Science1991;254:1756–61.
34.
HooverMLAngeliniGBallE. Insulin dependent diabetes mellitus is associated with polymorphic forms of the T cell receptor beta chain gene. Clin Res1986;34:725A.
35.
DemaineAGVaughanRWTaubeDHWelshKI. Association of membranous nephropathy with T-cell receptor constant beta chain and immunoglobulin heavy chain switch region polymorphisms. Immunogenetics1988;27:19–23.
36.
SchurPHPandeyJPFedrickJA. Gm allotypes in white patients with systemic lupus erythematosus. Arthritis Rheum1985;28:828–30.
